Skip to main content

Blood Product Usage in Liver Transplantation

  • Chapter
  • First Online:
Pediatric Liver Intensive Care
  • 676 Accesses

Abstract

Liver transplantation has emerged as an increasingly successful treatment for patients with end-stage liver disease (ESLD). The operative procedure is extensive, complex and technically challenging, with multiple vascular transections and anastomoses. Historically, liver transplantation was associated with massive blood loss and requires maximum component support amongst all organ transplants. Over the last few decades, with the continuous improvements in surgical techniques, use of pharmacological alternatives of blood and availability of potent immunosuppressive agents, there are remarkable improvements in survival outcomes of liver transplantation. General instructions of blood products handling and storage are outlined in Table 25.1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  1. Yusava N, Niwa N, Kimuara S, Tsuji H, Yurugi K, Egawa H, et al. Intraoperative blood loss during living donor liver transplantation: an analysis of 635 recipients at a single center. Transfusion. 2005;45:879–84.

    Article  Google Scholar 

  2. Rajesh K, Harsh S, Amarjit K. Effects of prestorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to red blood cells in a tertiary care hospital. Ann Med Health Sci Res. 2015;5:185–8.

    Article  CAS  Google Scholar 

  3. Wu Y, Zou S, Cable R, et al. Direct assessment of cytomegalovirus transfusion-transmitted risks after universal leukoreduction. Transfusion. 2010;50:776–86.

    Article  Google Scholar 

  4. Narvios AB, Lichtiger B. Bedside leukoreduction of cellular blood components in preventing cytomegalovirus transmission in allogeneic bone marrow transplant recipients: a retrospective study. Haematologica. 2001;86:749–52.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sachan, D. (2019). Blood Product Usage in Liver Transplantation. In: Shanmugam, N., Dhawan, A. (eds) Pediatric Liver Intensive Care. Springer, Singapore. https://doi.org/10.1007/978-981-13-1304-2_25

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-1304-2_25

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-1303-5

  • Online ISBN: 978-981-13-1304-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics